Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging
Sponsor: Poitiers University Hospital
Trial Details
| Condition | Development of the Virtual Biopsy, Tumor Grade, Artificial Intelligence Algorithms, Clinical, Radiological |
| Intervention | Diagnostic test |
| Phase | NA |
| Status | Recruiting |
| Participants | 500 |
| Est. Completion | 1 Feb 2029 |
| Last Updated | 8 May 2026 |
Primary Outcome
Validation of the virtual biopsy in the context of gliomas through the use of statistical learning algorithms (artificial intelligence) compared to the biopsy.
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Age≥ 18 years, * Patient with suspected glioma with prior imaging * Subject free, with legal protection guardianship or curatorship; * Enrollment in the French Social Security system; * Informed consent signed by the patient Exclusion Criteria: * Any contraindication to an MRI examination * Legal protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons residing in a health or social establishment, adults under legal protection and finally patients in emergency situations * Pregnant or lactating women, women of childbearing age who do not have effective contraception
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service